Senti Biosciences Holdings ISNTI
13F holders, Q2 2026 (June 30)19holders
1famous investor
$1.10avg. 13F price*
At the end of Q2 2026, 19 institutions reported holding Senti Biosciences Holdings I (SNTI) in their 13F filings. The largest holders were Nantahala Capital Management, LLC ($977K), Vanguard Capital Management LLC ($591K) and Geode Capital Management, LLC ($206K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Senti Biosciences Holdings I
- CUSIP
- 816944102
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $214K |
| Exits | 0 | $0 |
Ownership 19 holders
| Nantahala Capital Management, LLC | 0.06% | No change | 888,000 | $977K |
| Vanguard Capital Management LLC | 0.00% | No change | 537,504 | $591K |
| Geode Capital Management, LLC | 0.00% | Reduce -9.7% | 187,065 | $206K |
| Citadel Advisors | 0.00% | New | 107,100 | $118K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 91,193 | $100K |
| Jane Street Group, LLC | 0.00% | New | 52,530 | $58K |
| Menlo Ventures Management, L.P. | 0.01% | No change | 35,737 | $39K |
| Northern Trust Corp. | 0.00% | Add +91.6% | 32,154 | $35K |
| XTX Topco Ltd | 0.00% | Add +36.7% | 23,610 | $26K |
| Virtu Financial LLC | 0.00% | New | 22,795 | $25K |
| UBS Group AG | 0.00% | Add +67.1% | 14,432 | $16K |
| State Street Corp. | 0.00% | No change | 10,010 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,344 | $8K |
| BlackRock, Inc. | 0.00% | Reduce -84.0% | 4,004 | $4K |
| Royal Bank of Canada | 0.00% | New | 4,015 | $4K |
| Barclays PLC | 0.00% | New | 768 | $845 |
| SBI Securities Co., Ltd. | 0.00% | No change | 334 | $367 |
| Morgan Stanley | 0.00% | Add +5.6% | 169 | $186 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Holdings I the manager owns.